• Publications
  • Influence
21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study.
TLDR
The prevalence of hirsutism increased with age, suggesting the progressive nature of nonclassic adrenal hyperplasia, and the adrenocorticotropic hormone-stimulated levels but not the basal levels of 17-hydroxyprogesterone were significantly higher in patients with clitoromegaly than in women without clitoromeGaly. Expand
Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.
TLDR
This work underlines the importance of stroma measure in improving US diagnosis of PCOS and suggests that this parameter may be used in routine clinical practice as well as verifying the feasibility of S/A ratio in predicting hyperandrogenism in PCOS. Expand
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
TLDR
The risk of a mother with 21-OH-deficient NCAH for giving birth to a child affected with CAH is 2.5%; at least 14.8% of children born to these mothers have CAH. Expand
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
TLDR
Increase of type III or type IV LDL subclasses is a common finding in PCOS and represents the second most common lipid alteration after HDL-cholesterol decrease, however, in this PCOS patients, because of relatively low triglyceride levels, complete ALP is uncommon. Expand
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.
TLDR
The risk of metabolic alterations may vary in adolescent PCOS patients with different phenotypes, and hyperandrogenemia is a risk factor for dyslipidemia. Expand
Attitudes of Italian women concerning suppression of menstruation with oral contraceptives
TLDR
About 60% of Italian women with spontaneous or OC-driven cycles prefer to bleed less than monthly, and this fact should be kept in mind by physicians when prescribing OCs. Expand
The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome.
TLDR
Evidence is provided that estrogen is at least one factor that influences adrenal androgen sensitivity in PCO and may help explain the frequent finding of adrenal hyperandrogenism in this syndrome. Expand
Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
TLDR
It is demonstrated that women with polycystic ovary syndrome and insulin resistance show a blunted endothelial-dependent vasodilation and this hemodynamic and fibrinolytic derangement may contribute to the pathogenesis of early atherosclerosis in insulin resistance. Expand
Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism.
TLDR
It is suggested that pre menopausal administration of OC can prevent the acceleration of bone turnover and reverse the decrease in bone density that follows the premenopausal impairment of ovarian function. Expand
Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome.
TLDR
Naltrexone may have a beneficial effect on the clinical and endocrine-metabolic disturbances of obese PCOS women, whether these effects are the consequences of weight loss or are due to changes in opioidergic tone is debatable. Expand
...
1
2
3
4
5
...